John A. Schoenhard, Ph.D. - Publications

Affiliations: 
2002 Vanderbilt University, Nashville, TN 
Area:
Pharmacology, Molecular Biology, Animal Physiology Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Schoenhard JA, Asselbergs FW, Poku KA, Stocki SA, Gordon S, Vaughan DE, Brown NJ, Moore JH, Williams SM. Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population. Human Genetics. 124: 479-88. PMID 18953568 DOI: 10.1007/S00439-008-0573-X  0.506
2007 Schoenhard JA, Muldowney JA, Emens JS, Lewy AJ, Vaughan DE. Plasminogen activator inhibitor-1 has a circadian rhythm in blind individuals. Thrombosis and Haemostasis. 98: 479-81. PMID 17721638 DOI: 10.1160/Th06-12-0696  0.565
2004 Hou B, Eren M, Painter CA, Covington JW, Dixon JD, Schoenhard JA, Vaughan DE. Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. The Journal of Biological Chemistry. 279: 18127-36. PMID 14963043 DOI: 10.1074/Jbc.M310438200  0.57
2004 Muldowney JA, Roberts BC, Covington JW, Schoenhard JA, Brown NJ, Vaughan DE. 1007-182 Aldosterone and plasma renin activity influence plasma plasminogen activato inhibitor-1 levels in overweight subjects Journal of the American College of Cardiology. 43: A445. DOI: 10.1016/S0735-1097(04)91875-X  0.496
2003 Eren M, Painter CA, Gleaves LA, Schoenhard JA, Atkinson JB, Brown NJ, Vaughan DE. Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic mice. Journal of Thrombosis and Haemostasis : Jth. 1: 2389-96. PMID 14629474 DOI: 10.1046/J.1538-7836.2003.00437.X  0.568
2003 Schoenhard JA, Smith LH, Painter CA, Eren M, Johnson CH, Vaughan DE. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. Journal of Molecular and Cellular Cardiology. 35: 473-81. PMID 12738229 DOI: 10.1016/S0022-2828(03)00051-8  0.634
2002 Schoenhard JA, Eren M, Johnson CH, Vaughan DE. Alternative splicing yields novel BMAL2 variants: tissue distribution and functional characterization. American Journal of Physiology. Cell Physiology. 283: C103-14. PMID 12055078 DOI: 10.1152/Ajpcell.00541.2001  0.572
2002 Kaikita K, Schoenhard JA, Painter CA, Ripley RT, Brown NJ, Fogo AB, Vaughan DE. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition. Journal of Molecular and Cellular Cardiology. 34: 617-27. PMID 12054849 DOI: 10.1006/Jmcc.2002.2001  0.521
2002 Brown NJ, Abbas A, Byrne D, Schoenhard JA, Vaughan DE. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women. Circulation. 105: 304-9. PMID 11804984 DOI: 10.1161/Hc0302.102570  0.535
2002 Schoenhard JA, Vaughan DE. Transforming growth factor-b regulation of plasminogen activator inhibitor-1 gene expression at the 4G/5G polymorphism Journal of the American College of Cardiology. 39: 203-204. DOI: 10.1016/S0735-1097(02)80901-9  0.545
2001 Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation. 104: 839-44. PMID 11502712 DOI: 10.1161/Hc3301.092803  0.512
Show low-probability matches.